Literature DB >> 23884329

Deafness induction in mice.

Thijs T G Jansen1, Hendrik G Bremer, Vedat Topsakal, Ferry G J Hendriksen, Sjaak F L Klis, Wilko Grolman.   

Abstract

HYPOTHESIS: How to induce most efficiently severe sensorineural hearing loss in mice using a single coadministration of an aminoglycoside antibiotic and a loop diuretic?
BACKGROUND: The coadministration of aminoglycosides and a loop diuretic has been widely used to induce hair cell and spiral ganglion cell loss in guinea pigs. However, the development of new treatment strategies against sensorineural hearing loss, such as tissue engineering techniques, requires the use of mouse models. Previous attempts to induce hearing loss in mice have rendered inconsistent results because of resistance to aminoglycoside-induced ototoxicity. Especially inner hair cells seem to be resistant to aminoglycoside-induced ototoxicity.
METHODS: In the present study, we aim to optimize hearing loss in mice, using a single high-dose kanamycin (700 and 1,000 mg/kg) injection followed by a furosemide (100 mg/kg) administration. Although previous studies used intraperitoneal furosemide injections 30 minutes after kanamycin administration, we used intravenous furosemide injections administered within 5 minutes after kanamycin treatment.
RESULTS: Auditory brain stem responses illustrated severe threshold shifts, and histologic analysis showed marked outer hair cell destruction as well as spiral ganglion cell loss. The present protocol results in more severe inner hair cell loss when compared with the results of previous researches.
CONCLUSION: We conclude that severe sensorineural hearing loss can be induced in mice. Moreover, we found that this mouse model can be augmented via the use of rapid intravenous furosemide administrations to maximize inner hair cell loss.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23884329     DOI: 10.1097/MAO.0b013e318291c610

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

1.  Altered vesicular glutamate transporter distributions in the mouse cochlear nucleus following cochlear insult.

Authors:  A N Heeringa; R A Stefanescu; Y Raphael; S E Shore
Journal:  Neuroscience       Date:  2015-12-17       Impact factor: 3.590

2.  Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice.

Authors:  Shin Hye Kim; Gaon Jung; Sangjae Kim; Ja-Won Koo
Journal:  Front Cell Neurosci       Date:  2018-01-19       Impact factor: 5.505

Review 3.  Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk.

Authors:  Mark A Crumling; Kelly A King; R Keith Duncan
Journal:  Front Cell Neurosci       Date:  2017-11-08       Impact factor: 5.505

4.  Protocol for assessing auditory brainstem response in mice using a four-channel recording system.

Authors:  Lingling Zeng; Wen Zhou; Dan Bing; Li Xie; Xiaodi Wang; Guo Zhang
Journal:  STAR Protoc       Date:  2022-03-16

5.  Central Nervous Activity upon Systemic Salicylate Application in Animals with Kanamycin-Induced Hearing Loss--A Manganese-Enhanced MRI (MEMRI) Study.

Authors:  Moritz Gröschel; Romy Götze; Susanne Müller; Arne Ernst; Dietmar Basta
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

6.  Transient Receptor Potential Cation Channel Subfamily Vanilloid 4 and 3 in the Inner Ear Protect Hearing in Mice.

Authors:  Shengnan Wang; Qiaowei Geng; Lifang Huo; Yirui Ma; Yiting Gao; Wei Zhang; Hailin Zhang; Ping Lv; Zhanfeng Jia
Journal:  Front Mol Neurosci       Date:  2019-12-04       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.